Key facts
- This page summarizes Seth Lederman's Form 4 filing for Tonix Pharmaceuticals Holding Corp. (TNXP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Jun 2026, 17:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $11.735 to $11.883 per share. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Footnote F2
Reporting Person may be deemed a control person of this entity.